{
  "url": "https://openlegislation.uk/medicines-products-for-animal-usefees-regulations-1997/schedule-1/part-I",
  "json_url": "https://openlegislation.uk/medicines-products-for-animal-usefees-regulations-1997/schedule-1/part-I.json",
  "legislation": "uksi/1997/1469",
  "legislation_title": "The Medicines (Products for Animal Use—Fees) Regulations 1997",
  "legislation_url": "https://openlegislation.uk/medicines-products-for-animal-usefees-regulations-1997",
  "path": "schedule/1/part/I",
  "kind": "part",
  "number": "I",
  "heading": "INTERPRETATION",
  "text": "In this Schedule—\n“application for a type A marketing authorisation” means an application for a marketing authorisation to which regulation 5(a) of the 1994 Regulations applies and “type A marketing authorisation” shall be construed accordingly;\n“application for a type B marketing authorisation” means an application for a marketing authorisation to which regulation 5(b) of the 1994 Regulations applies and “type B marketing authorisation” shall be construed accordingly;\n“Article 15.2 marketing authorisation” means a marketing authorisation of the type specified in Article 15.2 of Directive 81/851/EEC;\n“category I application” means an application for assistance in connection with a mutual recognition application other than a category II or III application;\n“category II application” means an application, other than a category III application, for assistance in connection with a mutual recognition application relating to a marketing authorisation granted in respect of a Veterinary Medicinal Product only intended for administration to animals whose flesh or products are not intended for human consumption;\n“category III application” means an application for assistance in connection with a mutual recognition application relating to a marketing authorisation granted in respect of an immunological Veterinary Medicinal Product;\n“food-producing animals” means animals whose flesh or products are intended for human consumption;\n“type I variation—Administrative” means a variation of the type listed in paragraphs 2 and 3 of Annex I to Regulation (EC) No. 541/95;\n“type I variation—Scientific” means a variation of the type listed in paragraphs 1 and 4 to 33 of Annex 1 to Regulation (EC) No. 51/95; and\n“type II variation” means a variation of the type referred to in Article 3.1(b) of Regulation (EC) No. 541/95.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "OJ No. L55, 11.3.95, p.7."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/1997/1469/schedule/1/part/I",
    "retrieved_at": "2026-10-29T12:07:19.034510+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}